Pursuant to regulation 32(1) of SEBI(LODR) Regulation 2015, statement of Deviation or Variation as on year ended 31st March, 2026 is enclosed for utilization of funds raised through public issue
INNOVISION · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Innovision Limited filed its maiden post-IPO fund utilization statement for the year ended 31 March 2026. The company raised Rs 2,097.99 crore (net proceeds) via an IPO on 23 March 2026. The three intended uses were: repayment/prepayment of borrowings (Rs 510 crore), funding working capital requirements (Rs 1,190 crore), and general corporate purposes (Rs 397.99 crore). Of the 510 crore allocated for debt repayment, Rs 510 crore has been fully utilized. No funds have been deployed into working capital or general corporate purposes yet. CRISIL Ratings Limited is the monitoring agency. The company explicitly confirmed there is no deviation or variation in the use of funds.
No deviations detected, which is a positive signal that the IPO proceeds are being managed as per the disclosed plan. The full deployment of the debt repayment portion (Rs 510 crore) suggests the company is actively reducing its leverage. The zero utilization of the working capital and GCP buckets warrants monitoring in future quarters.